|
3 Companies |
|
1 Product |
|
1 Product |
|
0 Mechanisms of Action |
|
0 Trials |
|
4 News |
|
- | Trial completion: Cause, Development, and Progression of Stiff-Person Syndrome (clinicaltrials.gov) - Jun 30, 2017
P=N/A, N=40, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
No longer recruiting --> Completed
- Enrollment change, Trial termination, Trial primary completion date: Effects of Mutations of the Glycine Gene Associated With Hyperekplexia on Central Pain Processing (clinicaltrials.gov) - Sep 5, 2014
P=N/A, N=9, Terminated, Sponsor: University Hospital Inselspital, Berne
No longer recruiting --> Completed N=68 --> 9 | Recruiting --> Terminated | Trial primary completion date: Sep 2014 --> Dec 2012; Recruitment problems
- | Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
Trial completion: Rituximab to Treat Stiff Person Syndrome (clinicaltrials.gov) - Feb 22, 2014
P2, N=24, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
N=68 --> 9 | Recruiting --> Terminated | Trial primary completion date: Sep 2014 --> Dec 2012; Recruitment problems Active, not recruiting --> Completed